Ausgabe 3/2017
Inhalt (25 Artikel)
Current trends in mouse models of glioblastoma
Masafumi Miyai, Hiroyuki Tomita, Akio Soeda, Hirohito Yano, Toru Iwama, Akira Hara
Incidence and survival trends for medulloblastomas in the United States from 2001 to 2013
Vishesh Khanna, Rebecca L. Achey, Quinn T. Ostrom, Hunter Block-Beach, Carol Kruchko, Jill S. Barnholtz-Sloan, Peter M. de Blank
Overexpression of cytosolic, plasma membrane bound and extracellular heat shock protein 70 (Hsp70) in primary glioblastomas
Jun Thorsteinsdottir, Stefan Stangl, Peng Fu, Ketai Guo, Valerie Albrecht, Sabina Eigenbrod, Janina Erl, Mathias Gehrmann, Jörg-Christian Tonn, Gabriele Multhoff, Christian Schichor
Silencing Pre-B-cell leukemia homeobox 3 decreases the proliferation of human glioma cells in vitro and in vivo
Xiupeng Xu, Ning Cai, Zhongyuan Bao, Yongping You, Jing Ji, Ning Liu
Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil
Dayane B. Koshiyama, Patrícia Trevisan, Carla Graziadio, Rafael F. M. Rosa, Bibiana Cunegatto, Juliete Scholl, Valentina O. Provenzi, Alexandre P. de Sá, Fabiano P. Soares, Maíra C. Velho, Nelson de A. P. Filho, Ceres A. Oliveira, Paulo R. G. Zen
Implication of connexin30 on the stemness of glioma: connexin30 reverses the malignant phenotype of glioma by modulating IGF-1R, CD133 and cMyc
Sankaradoss Arun, Shantha Ravisankar, Arambakkam Janardhanam Vanisree
SHP2 regulates proliferation and tumorigenicity of glioma stem cells
Laura Roccograndi, Zev A. Binder, Logan Zhang, Nicola Aceto, Zhuo Zhang, Mohamed Bentires-Alj, Ichiro Nakano, Nadia Dahmane, Donald M. O’Rourke
Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy
Shailendra Joshi, Johann R. N. Cooke, Jason A. Ellis, Charles W. Emala, Jeffrey N. Bruce
Metastatic melanoma: prognostic factors and survival in patients with brain metastases
E. Frinton, D. Tong, J. Tan, G. Read, V. Kumar, S. Kennedy, C. Lim, R. E. Board
Clinical features and long-term outcomes of primary spinal malignant melanoma: a single center experience
Liang Wu, Ning Yao, Jingyi Fang, Jun Yang, Yulun Xu
Monte Carlo-driven predictions of neurocognitive and hearing impairments following proton and photon radiotherapy for pediatric brain-tumor patients
Dominique Fortin, Derek Tsang, Angela Ng, Normand Laperriere, David C. Hodgson
Association between hospital volume and receipt of treatment and survival in patients with glioblastoma
Matthew Koshy, David J. Sher, Michael Spiotto, Zain Husain, Herb Engelhard, Konstantin Slavin, Martin K. Nicholas, Ralph R. Weichselbaum, Chad Rusthoven
The impact of adjuvant therapy for patients with high-risk diffuse WHO grade II glioma
Ryan S. Youland, Cole R. Kreofsky, David A. Schomas, Paul D. Brown, Jan C. Buckner, Nadia N. Laack
Health-related quality of life, cognitive screening, and functional status in a randomized phase III trial (EF-14) of tumor treating fields with temozolomide compared to temozolomide alone in newly diagnosed glioblastoma
Jay-Jiguang Zhu, Petya Demireva, Andrew A. Kanner, Susan Pannullo, Maximilian Mehdorn, Nicholas Avgeropoulos, Andrea Salmaggi, Antonio Silvani, Samuel Goldlust, Carlos David, Alexandra Benouaich-Amiel
The preliminary radiogenomics association between MR perfusion imaging parameters and genomic biomarkers, and their predictive performance of overall survival in patients with glioblastoma
Xiang Liu, Rajiv Mangla, Wei Tian, Xing Qiu, Dongmei Li, Kevin A. Walter, Sven Ekholm, Mahlon D. Johnson
Correlation between arterial spin-labeling perfusion and histopathological vascular density of pediatric intracranial tumors
Kazufumi Kikuchi, Akio Hiwatashi, Osamu Togao, Koji Yamashita, Koji Yoshimoto, Masahiro Mizoguchi, Satoshi O. Suzuki, Toru Iwaki, Yuriko Suzuki, Hiroshi Honda
Epidemiology of glioma: clinical characteristics, symptoms, and predictors of glioma patients grade I–IV in the the Danish Neuro-Oncology Registry
Birthe Krogh Rasmussen, Steinbjørn Hansen, René J. Laursen, Michael Kosteljanetz, Henrik Schultz, Bente Mertz Nørgård, Rikke Guldberg, Kim Oren Gradel
Salvage re-irradiation for recurrent high-grade glioma and comparison to bevacizumab alone
Nils D. Arvold, Diana D. Shi, Ayal A. Aizer, Andrew D. Norden, David A. Reardon, Eudocia Q. Lee, Lakshmi Nayak, Ian F. Dunn, Alexandra J. Golby, Mark D. Johnson, Elizabeth B. Claus, E. Antonio Chiocca, Keith L. Ligon, Patrick Y. Wen, Brian M. Alexander
Skin toxicities associated with tumor treating fields: case based review
Rimas V. Lukas, Kelley L. Ratermann, Eric T. Wong, John L. Villano
Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Rachel L. Delfanti, David E. Piccioni, Jason Handwerker, Naeim Bahrami, AnithaPriya Krishnan, Roshan Karunamuni, Jona A. Hattangadi-Gluth, Tyler M. Seibert, Ashwin Srikant, Karra A. Jones, Vivian S. Snyder, Anders M. Dale, Nathan S. White, Carrie R. McDonald, Nikdokht Farid
Erratum to: Imaging correlates for the 2016 update on WHO classification of grade II/III gliomas: implications for IDH, 1p/19q and ATRX status
Rachel L. Delfanti, David E. Piccioni, Jason Handwerker, Naeim Bahrami, AnithaPriya Krishnan, Roshan Karunamuni, Jona A. Hattangadi-Gluth, Tyler M. Seibert, Ashwin Srikant, Karra A. Jones, Vivian S. Snyder, Anders M. Dale, Nathan S. White, Carrie R. McDonald, Nikdokht Farid
Resident participation is not associated with postoperative adverse events, reoperation, or prolonged length of stay following craniotomy for brain tumor resection
Nikita Lakomkin, Constantinos G. Hadjipanayis
Estimating progression-free survival in patients with glioblastoma using routinely collected data
Charlotte Kelly, Paulina Majewska, Stefanos Ioannidis, Muhammad Hasan Raza, Matt Williams
Role of radiation therapy in primary central nervous system lymphoma
Hyeon Kang Koh, Il Han Kim, Tae Min Kim, Do Hoon Lim, Dongryul Oh, Jae Ho Cho, Woo-Chul Kim, Jin Hee Kim, Woong-Ki Chung, Bae-Kwon Jeong, Ki Mun Kang, Semie Hong, Chang-Ok Suh, In Ah Kim
Her2 positive subtype and breast cancer brain metastasis: any effect of anti-Her2 targeted therapy?
Kadri Altundag